Litcius/Paper detail

Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2

Solomon Habtemariam, Seyed Fazel Nabavi, Saeid Ghavami, Cosmin Andrei Cismaru, Ioana Berindan‐Neagoe, Seyed Mohammad Nabavi

2020Pharmacological Research44 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDrugSerine proteasePharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HydrochlorideProteaseCoronavirus disease 2019 (COVID-19)VirologyChemistryEnzymeInternal medicineBiochemistryInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2 | Litcius